Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
19.36
+1.67 (9.44%)
At close: Jul 9, 2026
-15.64% (1Y)
| Market Cap | 223.78M +60.5% |
| Revenue (ttm) | 80.25M +894.0% |
| Net Income | 2.48M |
| EPS | 0.21 |
| Shares Out | 11.58M |
| PE Ratio | 92.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,861 |
| Open | 18.00 |
| Previous Close | 17.69 |
| Day's Range | 18.00 - 19.95 |
| 52-Week Range | 16.00 - 36.96 |
| Beta | -2.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |